stem cell-based assay
Johns Hopkins, NYSCF Collaborate on Stem Cell Models of Disease for Precision Medicine
The collaborators hope to establish new models of human disease using patient-derived stem cells, with support from Bloomberg Philanthropies.
Amarantus Reacquires Neurology Diagnostic Assets from Avant
Amarantus has reacquired LymPro Test, MSPrecise, and NuroPro and said that it plans to assign the assets to a new subsidiary.
Ncardia, Evotec Sign Licencing Agreement for iPS Cell Disease Modeling
Evotec will gain non-exclusive rights to Ncardia IP, including a broad panel of stem cell-derived cell lines for use in drug target discovery and testing.
Cellular Dynamics International, Nanion Technologies Ink Comarketing Pact
The companies will offer CDI's human induced pluripotent stem cell-derived tissue cells with Nanion's ion channel drug discovery and screening platform.
New Studies Demonstrate Utility of iPSC Technology for Genetic Research
Eleven new studies from the NHLBI NextGen Consortium show different uses for iPSCs to study polygenetic diseases across various systems in the human body.
Jun 2, 2014
Definigen Closes $3.8M Series A Round
Nov 2, 2011
ILS, Stemina Partner on Toxicity Screening
Jun 30, 2010